VBI Vaccines, Inc.VBI Vaccines, Inc.VBI Vaccines, Inc.

VBI Vaccines, Inc.

No trades
See on Supercharts
Market capitalization
‪13.74 M‬USD
−11.8703USD
‪−113.30 M‬USD
‪1.08 M‬USD
‪22.28 M‬
Beta (1Y)
2.43

About VBI Vaccines, Inc.

CEO
Jeffrey R. Baxter
Headquarters
Cambridge
Employees (FY)
190
Founded
1965
ISIN
CA91822J2020
FIGI
BBG000BB3S61
VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of infectious disease and immuno-oncology vaccines. The firm focuses on the prevention and treatment of hepatitis B through its product pipeline, Sci-B-Vac and VBI-2601. It also develops an enveloped virus-like particle (eVLP) platform technology, which allows the development of eVLP vaccines that closely mimic the target virus to elicit a potent immune response. The company was founded on April 9, 1965 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VBIV is 0.5800 USD — it has decreased by 3.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange VBI Vaccines, Inc. stocks are traded under the ticker VBIV.
VBI Vaccines, Inc. is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
VBIV earnings for the last quarter are −0.38 USD whereas the estimation was −0.14 USD which accounts for −171.43% surprise. Estimated earnings for the next quarter are −0.22 USD. See more details about VBI Vaccines, Inc. earnings.
VBI Vaccines, Inc. revenue for the last quarter amounts to ‪6.62 M‬ USD despite the estimated figure of ‪13.25 M‬ USD. In the next quarter revenue is expected to reach ‪5.36 M‬ USD.
Yes, you can track VBI Vaccines, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, VBIV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VBI Vaccines, Inc. stock right from TradingView charts — choose your broker and connect to your account.
VBIV reached its all-time high on Aug 1, 2005 with the price of 59640.0000 USD, and its all-time low was 0.4500 USD and was reached on Oct 25, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 14, 2024, the company has 190.00 employees. See our rating of the largest employees — is VBI Vaccines, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VBI Vaccines, Inc. EBITDA is ‪−61.70 M‬ USD, and current EBITDA margin is ‪−7.37 K‬%. See more stats in VBI Vaccines, Inc. financial statements.